"ながぴい"さん指摘の、「ホメオパシーをNHSの対象にしなように求めた英国下院科学技術委員会報告に対する英国政府保健省の回答の41項目」にある「In recent years the MHRA has removed from the market homeopathic products being promoted for the prevention of malaria and the treatment of cancer.」について。41. The fact that homeopathic medicinal products come within a regulatory scheme strengthens the ability of MHRA to take regulatory action where inappropriate claims are made